C07K14/765

MT-45 IMMUNODETECTION

Components for enabling immunodection of MT-45 are described including immunogens, antibodies derived from the immunogens, immunoassay methods, detecting agents and kits.

MT-45 IMMUNODETECTION

Components for enabling immunodection of MT-45 are described including immunogens, antibodies derived from the immunogens, immunoassay methods, detecting agents and kits.

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.

Compositions and methods of use for treating metabolic disorders

Methods of treating individuals with a glucose metabolism disorder and/or a body weight disorder, and compositions associated therewith, are provided.

PURIFICATION METHOD OF CHARGED MATERIAL
20230174573 · 2023-06-08 · ·

An object of the present invention is to suppress the variation of the elution position of a compound having a charged portion by a preservation liquid, in the purification of the compound, without carrying out the substitution step of the preservation liquid attached to the adsorbent used for the purification and the keeping step. A method for purifying a compound having a charged portion, the method comprising the steps of: preparing a composition containing a compound having a charged portion; preparing a buffer solution comprising a buffering agent and an alcohol, the buffer containing a calcium phosphate compound at least partially, having a buffer capacity in a range of pH 6.0 to pH 8.0, and being soluble in a polar solvent and insoluble in a non-polar solvent; preserving an adsorbent in the buffer solution; adsorbing the compound on the adsorbent by bringing the composition into contact with the adsorbent preserved in the buffer solution; and separating the compound from the adsorbent by gradient elution.

REAGENT KIT AND METHOD FOR REMOVING BACTERIAL ENDOTOXIN IN BIOLOGICAL PRODUCT
20170334949 · 2017-11-23 ·

Disclosed are a reagent kit for removing a bacterial endotoxin in a biological product, a method for using the reagent kit for removing the bacterial endotoxin in the biological product, a method for preparing an endotoxin-free biological product, and the endotoxin-free biological product thus produced. The reagent kit of the present invention comprises an anionic surfactant and a potassium salt. When in use, the anionic surfactant is fully bonded with the endotoxin in the biological product to form a conjugate, then the potassium salt is added to precipitate the conjugate, the precipitate is removed by filtration to produce a biological product solution with the endotoxin removed, and then the biological product is separated from the biological product solution to complete the process.

REAGENT KIT AND METHOD FOR REMOVING BACTERIAL ENDOTOXIN IN BIOLOGICAL PRODUCT
20170334949 · 2017-11-23 ·

Disclosed are a reagent kit for removing a bacterial endotoxin in a biological product, a method for using the reagent kit for removing the bacterial endotoxin in the biological product, a method for preparing an endotoxin-free biological product, and the endotoxin-free biological product thus produced. The reagent kit of the present invention comprises an anionic surfactant and a potassium salt. When in use, the anionic surfactant is fully bonded with the endotoxin in the biological product to form a conjugate, then the potassium salt is added to precipitate the conjugate, the precipitate is removed by filtration to produce a biological product solution with the endotoxin removed, and then the biological product is separated from the biological product solution to complete the process.

PROTOXIN-II VARIANTS AND METHODS OF USE
20170334959 · 2017-11-23 ·

The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.